M. Boffa

666 total citations
14 papers, 465 citations indexed

About

M. Boffa is a scholar working on Computational Theory and Mathematics, Molecular Biology and Rheumatology. According to data from OpenAlex, M. Boffa has authored 14 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Computational Theory and Mathematics, 3 papers in Molecular Biology and 3 papers in Rheumatology. Recurrent topics in M. Boffa's work include Systemic Lupus Erythematosus Research (3 papers), semigroups and automata theory (2 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (2 papers). M. Boffa is often cited by papers focused on Systemic Lupus Erythematosus Research (3 papers), semigroups and automata theory (2 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (2 papers). M. Boffa collaborates with scholars based in France, Belgium and Italy. M. Boffa's co-authors include Yehuda Shoenfeld, G. Balestrieri, Massimo Cinquini, Marielle Sanmarco, Pier Luigi Meroni, Flavio Allegri, Marco Taglietti, Takao Koike, Kenji Ichikawa and A. Tincani and has published in prestigious journals such as The American Journal of Medicine, Thrombosis and Haemostasis and International Immunology.

In The Last Decade

M. Boffa

14 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Boffa France 10 223 215 120 71 66 14 465
Conley Cl United States 10 317 1.4× 245 1.1× 81 0.7× 46 0.6× 60 0.9× 15 579
Barbara Montaruli Italy 13 313 1.4× 256 1.2× 51 0.4× 51 0.7× 69 1.0× 32 444
Szu‐Hee Lee Australia 10 65 0.3× 92 0.4× 58 0.5× 12 0.2× 12 0.2× 20 329
A. López Borrasca Spain 14 17 0.1× 522 2.4× 44 0.4× 70 1.0× 30 0.5× 30 707
L. J. Downing United States 9 11 0.0× 197 0.9× 115 1.0× 285 4.0× 23 0.3× 11 453
R. Grace United Kingdom 8 9 0.0× 147 0.7× 106 0.9× 14 0.2× 18 0.3× 17 352
Eduard M. Walthers Germany 9 67 0.3× 30 0.1× 104 0.9× 6 0.1× 61 0.9× 28 354
Sireesha Yedururi United States 11 33 0.1× 35 0.2× 99 0.8× 7 0.1× 62 0.9× 40 392
HM Tsai United States 8 15 0.1× 799 3.7× 114 0.9× 17 0.2× 14 0.2× 11 1.2k
Makoto Hashimoto Japan 11 16 0.1× 62 0.3× 159 1.3× 4 0.1× 28 0.4× 61 395

Countries citing papers authored by M. Boffa

Since Specialization
Citations

This map shows the geographic impact of M. Boffa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Boffa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Boffa more than expected).

Fields of papers citing papers by M. Boffa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Boffa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Boffa. The network helps show where M. Boffa may publish in the future.

Co-authorship network of co-authors of M. Boffa

This figure shows the co-authorship network connecting the top 25 collaborators of M. Boffa. A scholar is included among the top collaborators of M. Boffa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Boffa. M. Boffa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Alarcón-Segovia, D, M. Boffa, Ware Branch, et al.. (2003). Prophylaxis of the antiphospholipid syndrome: a consensus report. Lupus. 12(7). 499–503. 62 indexed citations
2.
Blank, Miri, Yehuda Shoenfeld, Sigal Tavor, et al.. (2002). Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells. International Immunology. 14(2). 121–129. 93 indexed citations
3.
Allegri, Flavio, Marielle Sanmarco, Massimo Cinquini, et al.. (2001). Anticardiolipin Antibody Assay: a Methodological Analysis for a better Consensus in Routine Determinations. Thrombosis and Haemostasis. 86(8). 575–583. 144 indexed citations
4.
Balestrieri, G., et al.. (2000). Overview on Anticardiolipin ELISA Standardization. Journal of Autoimmunity. 15(2). 195–197. 13 indexed citations
5.
Boffa, M.. (1998). More on an undecidability result of Bateman, Jockusch and Woods. Journal of Symbolic Logic. 63(1). 50–50. 2 indexed citations
6.
7.
Cacoub, P., Marina Karmochkine, Richard Dorent, et al.. (1996). Plasma levels of thrombomodulin in pulmonary hypertension. The American Journal of Medicine. 101(2). 160–164. 49 indexed citations
8.
Boffa, M.. (1995). Une condition impliquant toutes les identités rationnelles. RAIRO - Theoretical Informatics and Applications. 29(6). 515–518. 15 indexed citations
9.
Boutière, B., D Arnoux, M. Boffa, et al.. (1994). Plasma thrombomodulin in orthotopic liver transplantation.. PubMed. 58(12). 1352–5. 2 indexed citations
10.
11.
Boffa, M.. (1984). Arithmetic and the theory of types. Journal of Symbolic Logic. 49(2). 621–624. 3 indexed citations
12.
Boffa, M., Denis Labarre, M. Jozéfowicz, & G. A. Boffa. (1979). Interactions between Human Plasma Proteins and Heparin-Poly(Methyl Methacrylate) Copolymer. Thrombosis and Haemostasis. 41(2). 346–356. 21 indexed citations
13.
Boffa, M.. (1977). The consistency problem for NF. Journal of Symbolic Logic. 42(2). 215–220. 11 indexed citations
14.
Boffa, M., P. Delori, & J P Soulier. (1972). Anticoagulant Factors from Viperidae Venoms. Thrombosis and Haemostasis. 28(3). 509–523. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Conley Cl Breakdown of academic impact, for papers by Barbara Montaruli Breakdown of academic impact, for papers by Szu‐Hee Lee Breakdown of academic impact, for papers by A. López Borrasca Breakdown of academic impact, for papers by L. J. Downing Breakdown of academic impact, for papers by R. Grace Breakdown of academic impact, for papers by Eduard M. Walthers Breakdown of academic impact, for papers by Sireesha Yedururi Breakdown of academic impact, for papers by HM Tsai Breakdown of academic impact, for papers by Makoto Hashimoto
Rankless by CCL
2026